The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...

President Donald Trump said Wednesday that he is directing the opening of a detention center at Guantanamo Bay to hold up to ...

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...